1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow SAR: new trials by email Literature Review of SAR trials Research Report on SAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC CBDRA60 supplement, Placebo - COVID-19, SAR | Not applicable | Unknown | Anewsha Therapeutics Inc. | 60 | 2022-07-01 | 2022-02-22 |
COVID-19 (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
United States (1)